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Background/aim: In this study, we evaluate sciatic nerve injuries due to intramuscular injections, which is an important medicolegal
problem frequently encountered in medical practice, with an extended experimental rat model of peripheral nerve injury.
Materials and methods: A total of 78 male Wistar albino rats were divided into five main groups, including a control group, a sham saline
group, and groups that received benzathine penicillin G, diclofenac sodium, and dexamethasone, respectively. These pharmaceutical
agents were applied to the sciatic nerves of all rats after exploration in the epineurial, endoneurial, and intrafascicular compartments,
excluding the control group. Outcomes were evaluated for all rats and their sciatic nerves according to functional, electrophysiological,
and histopathological results.
Results: Injuries were most evident in the groups that received penicillin G and diclofenac sodium, and this finding was statistically
significant. It was also found that endoneurial and intrafascicular injections may cause more harm than epineurial injections.
Conclusion: We have demonstrated that any medical injections applied to the epineurial, endoneurial, or intrafascicular compartments
of the sciatic nerve may cause functional and electrophysiological loss with or without deterioration of the peripheral nerve architecture.
Key words: Sciatic nerve, injection injury, peripheral nerve, electroneuromyography

1. Introduction
Intramuscular injections (IMIs) are common medical
applications today as they can be easily applied to the
gluteal, quadriceps, and deltoid muscles. However, as
a result of incorrect applications, severe disorders may
arise. According to global data from the World Health
Organization, 50% of all IMIs are administered incorrectly
and 75% are administered unnecessarily [1,2]. Abscesses,
necrosis, contracture, periostitis, and peripheral nerve
injuries may occur following incorrect applications
of IMIs [1–5]. Peripheral nerve injection injuries are
caused by the application of the needle directly to the
nerve fiber or somewhere near the nerve fiber and they
are strongly associated with the neurotoxic effects of the
drug; the penetration of the needle is not the reason for
the nerve injury [4]. High volumes of medications may
also cause nerve injury due to compression. Experimental
studies have shown that minimal damage may occur after
epineurial injections of pharmaceutical agents, but for
severe damage, endoneurial or intrafascicular penetration
of the agent is necessary [2].
The sciatic nerve is the nerve that is most commonly
injured by IMIs. Peripheral nerve injection injury is reported
at a rate of 2% in the literature [5–7]. Sciatic nerve injury

due to gluteal IMI has a wide range of clinical presentations,
but the most common complaints are posterolateral gluteal
neuropathic pain and sensorial or motor deficiencies [8,9].
The clinical symptoms of the patient may be observed
immediately after the injection or may develop later [7].
There are many anatomical, clinical, and experimental
studies in the literature regarding nerve injection injuries,
but the present study is unique as it was designed to
compare all possible injection injury mechanisms.
In this experimental study, we evaluate the effects
of the most commonly used IMI drugs (benzathine
penicillin G, diclofenac sodium, dexamethasone, and
saline) when injected into the epineurial, endoneurial,
and intrafascicular compartments of the peripheral
nerve in terms of electromyographic, functional, and
histopathological characteristics.
2. Materials and methods
This experimental study has been done under the approval
of XXX University, Animal Experiments Local Ethics
Committee Presidency with reference number 75296309050.01.04-E.1600181052/132.
This study was performed with 78 male Wistar albino
rats that weighed 200–250 g. The rats were divided into
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five main groups, including a control group, a sham saline
group, and groups that received benzathine penicillin
G, diclofenac sodium, and dexamethasone, respectively.
Excluding the control group, all groups were also
divided according to the epineurial, endoneurial, and
intrafascicular drug application compartments. Each
subgroup consisted of 6 rats. Six rats were also preserved
to reveal normal histology. During this study 11 rats died
and they were excluded out from the result and statistical
analysis.
After 12 h of fasting, the rats were prepared for the
experiment. Ketamine hydrochloride and xylazine were
applied intraperitoneally for general anesthesia. A right
gluteal oblique incision was performed and after muscular
dissection, the sciatic nerves of the rats were exposed. Initial
electromyography (EMG) recordings were performed
for the sciatic nerve and the results were recorded. For
these EMG recordings, a Cadwell Cascade Elite electroneuromonitoring device was used (Cadwell, Kennewick,
WA, USA). The pharmaceutical agents were injected
with a 30-G needle into the appropriate compartment
for each subgroup in an amount of 0.5 cc. (Figure 1).
Acute amplitude changes were recorded by EMG after the
injections as the second EMG recording. The injection
sites were marked with 3/0 silk muscle suturing to make it
easier to identify the injury zone in the follow-up period.
The wounds were closed properly.
In the postoperative period, rats were placed in single
cages in a room with normal temperature and daily
dressings of povidone-iodine were applied. Amoxicillinclavulanic acid was added to animal feed as a prophylactic
antibiotic. After 14 days, the third EMG recordings were
performed for all rats and injured sciatic nerves were
excised. During electrophysiological examinations, motor
action potentials were recorded in millivolts (mV) and
analyzed as needle electrode readings. The first amplitude
value recorded from the sciatic nerve after the initial
exploration before the application of any pharmaceutical
agents was taken as the first reading. The second amplitude
values recorded after the application of pharmaceutical
agents to the epineurial, endoneurial, and intrafascicular
compartments were taken as the second readings. The

third amplitude values recorded during the reexploration
of the sciatic nerve in the final stage of the experiment
after 14 days were taken as the third reading (Table 1).
During the 14-day period following the application of
the pharmaceutical agents, neurological evaluations were
also performed based on walking track analysis, extensor
postural thrust (EPT), and the presence of drop-foot
(Tables 2, 3) [10,11].
Sciatic nerve samples were collected for pathological
examination to reveal the sciatic nerve morphology and
presence of inflammation, edema, and congestion by H&E
staining. Masson’s trichrome stain was applied to reveal
perineural fibrosis and toluidine blue stain was applied
to reveal Wallerian degeneration. All of these samples
were examined by two independent pathologists under
a light microscope (Axio Scope A1, ZEISS, Oberkochen,
Germany). Histopathological data were evaluated with
a modified histopathological grading scale based on the
criteria of Faroni et al. (Table 4) [12].
2.1. Statistical analysis
All statistical analyses were done with IBM SPSS Statistics
19.0 for Windows (IBM Corp., Armonk, NY, USA). The
normal distribution of the variables was analyzed by
Shapiro-Wilk. Normal distribution was not detected in
most of the variables, so the Kruskal Wallis test was used
for intergroup comparison and the Friedman test for ingroup repeated measurement comparison.
3. Results
Rats that received epineurially injected saline, penicillin
G, diclofenac sodium, and dexamethasone did not show
any differences in EPT tests and no drop-foot or dragging
of the feet was observed in these rats. In the epineurial
injection subgroups, electrophysiological changes were
not recorded. Macroscopically, there was only mild
congestion, and in microscopic evaluations, only Grade 1
changes were observed.
Endoneurial injections revealed no significant
differences, except for penicillin G and diclofenac sodium.
We found statistically significant differences in the EPT
test results for the subgroup endoneurially injected with
penicillin G and diclofenac sodium (p < 0.05). In penicillin

Figure 1. Surgical technique: dissection of the gluteal region of the rat, exposure of the
sciatic nerve, and endoneurial injection.
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Table 1. Comparison of all groups according to EMG recordings.
mV: milivolt, p*: Friedman Test, p**: Kruskal Wallis Test
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Table 2. Comparison of all groups in the EPT (extensor postural thrust) test.
g: gram, p*: Friedman Test, p**: Kruskal Wallis Test
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Table 3. All groups were compared for drop-foot and dragging existance (number of test subjects / positive existance).
Test

Epineurial Dropfoot, dragging

p*

Endoneurial Dropfoot, dragging

p*

Intrafascicular Dropfoot, dragging

p*

Sham (Saline)

5/0

N/A

5/0

N/A

6/0

N/A

Penicillin G

6/0

N/A

4/4

0.018

5/5

0.007

Diclofenac sodium

5/0

N/A

5/0

N/A

5/5

0.007

Dexamethasone

5/0

N/A

5/0

N/A

5/0

p**

N/A

Drug

<0.001

<0.001

p* Friedman Test, p** Kruskal Wallis Test

Table 4. Modified histopathological grading scale from Faroni et al.

Pathology

Fibrosis

Score

Criteria (cross-section, 40× magnification)

Grade 1

˂150 fibroblasts

Grade 2
Grade 3
Grade 1

Wallerian degeneration

Grade 2
Grade 3
Grade 1

Edema

Grade 2
Grade 3
Grade 1

Inflammatory cell infiltration

Grade 2
Grade 3

G subgroup both drop-foot and dragging of the feet were
observed in these rats (p < 0.05). Electrophysiological
changes also had statistical importance in all
endoneurial injection groups (p < 0.05). Furthermore,
histopathologically, perineural fibrosis was evaluated as
Grade 3 in this subgroup and intraneural inflammatory
cell infiltration and Wallerian degeneration were evaluated
as nearly Grade 2 (Figure 2).
Statistically significant results were also found among
the intrafascicular injection subgroups. The EPT test
results showed an average difference of 13.2 g for the
penicillin G subgroup and an average difference of 6.4 g for
the diclofenac sodium subgroup (p < 0.05). Interestingly in

100–150 fibroblasts
˃150 fibroblasts

˂25% degeneration

25%–75% degeneration
˃75% degeneration
˂25%

25%–75%
˃75%

0–10 neutrophils
10–50 neutrophils
˃50 neutrophils

dexamethasone subgroups EPT test resulted as statistically
significant (p < 0.05). There were also statistically
significant differences in all intrafascicular subgroups
among the results for electrophysiological changes (p <
0.05). Microscopic histopathological evaluations showed
Grade 2-3 inflammatory cell infiltration and Wallerian
degeneration for both penicillin G and diclofenac sodium,
but no fibrosis was observed (Figures 3 and 4).
Drop-foot developed over the course of 14 days for
all rats that received endoneurial and intrafascicular
injections of penicillin G and diclofenac sodium, and the
results of walking track analysis for foot dragging were
positive and statistically significant in these subgroups (p
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< 0.05). EPT analysis showed no statistically significant
results for any pharmaceutical agents administered by
epineurial injection (p ˃ 0.05). EPT results obtained after
the administration of penicillin G to the intrafascicular
compartment were found to be statistically significant
(p < 0.05) upon comparisons of all three compartment
groups for endoneurial injections. Endoneurial injection
of diclofenac sodium also showed statistically significant
results (p < 0.05) in EPT analysis. Furthermore, the
subgroup that received intrafascicular dexamethasone had
statistically significant results (p < 0.05) in the third EPT
analysis when compared to the epineurial and endoneurial
injections of the considered pharmaceutical agents.
The presence of drop-foot and positive results in
walking track analysis were statistically correlated with
Wallerian degeneration and the presence of perineural
fibrosis, which are highly associated with neural

degeneration and clinical disorders. Both of these findings
were present for the subgroup endoneurially injected with
penicillin G and the subgroup intrafascicularly injected
with diclofenac sodium.
The results for all three EMG readings were statistically
examined and correlations with functional evaluations were
sought. There were no statistically significant differences
in this regard after the epineurial drug injections (p ˃
0.05). Endoneurial injections of all drugs had a statistically
significant relationship with decreased EMG amplitudes
(p ˂ 0.05). Decreased amplitudes in the subgroups
administered intrafascicular injections of penicillin G
and diclofenac sodium were also statistically significant
(p ˂ 0.05). When all of the considered compartments
and pharmaceutical agents were compared, the most
statistically significant low amplitudes were seen in the
penicillin G and diclofenac sodium subgroups (p ˂ 0.05).

Figure 2. Fibrosis after endoneurial penicillin G injection:
peroneal branch (pd) and tibial branch (td) are surrounded
by fibrosis with fibroblast proliferation (f) (Masson’s trichome
staining, 40× magnification).

Figure 3. Inflammation and edema after interfascicular injection
of penicillin G: intraneural inflammatory cell infiltration (i),
edema due to inflammatory response (e), and congestion are
seen (H&E staining, 40× magnification).
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Figure 4. Wallerian degeneration after intrafascicular
penicillin G injection: axonal injury and myelin loss (m)
with Wallerian degeneration (w) (toluidine blue staining,
40× magnification).

4. Discussion
In neurosurgical practice, peripheral nerve injuries are
often seen. The most common causes of these injuries
are trauma, crushing, exposure to pressure, laceration,
surgical procedures around the hip joint, stretching, and
chemical injuries. Injection neuropathies are categorized
as chemical injuries and the annual incidence is reported
as 2% [6,7]. The sciatic nerve (55%), radial nerve (24%),
and femoral nerve (15%) are the nerves for which injection
neuropathies are most commonly observed [5]. Naturally,
there are vascular structures and nerves inside or around
muscle groups, and the inattentive administration of
injections in these important structures may cause injuries.
There is serious potential for morbidity as a result of the
neurotoxic effects of pharmaceutical agents in the event of
such injections into peripheral nerves [1,2,8,13,14].
In a study conducted by Kline et al., the etiology of
136 cases of 230 sciatic nerve injuries was reported to be
gluteal intramuscular injection [3]. The exact incidence
rate of such injuries may be higher than what is reported
because intramuscular injections and injection injuries
may not always be officially recorded in efforts to protect
health professionals from medicolegal troubles or for
other sociocultural reasons. Thus, the true incidence of
these injection injuries may be masked.
The ventrogluteal region and the vastus lateralis of the
quadriceps femoris muscles are often preferred for IMIs

for easy applicability, adequate distance from important
anatomic structures, and the capability of receiving
larger drug volumes. Ventrogluteal region injections
are also advantageous because it is easy to determine
the injection site, making IMIs safer, and the injection
site does not change due to positioning, so IMIs can be
administered here regardless of whether the patient is
supine, prone, or laterally positioned [1]. IMIs should be
applied more carefully for obese patients, because finding
the right injection site may be a challenge due to palpation
difficulties. The gluteal muscles are not yet fully developed
in pediatric patients and gluteal IMIs should therefore not
be applied in this population. They should be avoided for
cachectic patients for a similar reason, as was confirmed
by Yaremeyeva et al. in a study of injury predisposition
among cachectic patients [14]. It should be noted that
the sciatic nerve has seven different variations, but all
variations associated with the dorsogluteal region should
be avoided while administering IMIs. On the other hand,
the ventrogluteal region is safe if proper IMI applications
are administered according to this anatomical knowledge
[1,15–17]. This accordingly raises questions of medicolegal
issues or malpractice.
The biochemical characteristics of an administered
drug are also important factors for the occurrence of
neuropathy. The drugs commonly administered by IMI
are produced in solution, suspension, or emulsion forms.
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Fat-soluble vitamins, ferrous preparations, and procaine
penicillin accumulate in muscle tissues and are absorbed
slowly into the systemic circulation [17]. These kinds
of pharmaceutical agents may leak out of the tissues in
which they have accumulated and reach neural structures,
causing neural injuries to occur [18]. The amount of the
injected drug is another important issue for injection
neuropathy because higher volumes are absorbed more
slowly, making leakage and pressure more possible. Drug
injection volumes are recommended as 3–5 mL for the
gluteal muscles and 2 mL for the deltoid muscles [1].
In cases of injection neuropathy, the damage specifically
occurs around the nerve, in the neural sheath, or in the
neural fibers. The experiment presented here was designed
with that fact in mind. The chosen pharmaceutical
agents (saline, penicillin G, diclofenac sodium, and
dexamethasone) are commonly used in general medical
practice and may have neurotoxic effects. The injection
of these agents into the epineurial, endoneurial, and
intrafascicular compartments has been evaluated in
this study neurologically, electrophysiologically, and
histopathologically. With this experimental design, we
evaluated the effects of each pharmaceutical agent for each
of the three compartments. Any pharmaceutical agent
applied to a peripheral nerve, regardless of its chemical
properties, can cause an inflammatory reaction in the
epineurial, endoneurial, or intrafascicular compartments;
thus, edema and fibrosis may occur. This inflammatory
response may cause nerve injury in turn as a result of
microcirculatory changes and ischemia [7,8,19].
The epineurial compartment is important because it
is the space in which pathological changes occur with the
compression of the peripheral nerve due to fibrosis or scar
formation caused by inflammatory changes [2,8,13,10,20].
In this study, we demonstrated that the needle penetration
into the nerve body alone is not what causes the injury.
The endoneurial compartment works as a shock absorber
for peripheral nerves and it can stretch longitudinally.
The injection of a drug into this compartment causes
nerve injury by increasing both the pressure and chemical
toxicity. This increased pressure in the endoneurial
compartment results in ischemia and damage in sensitive
neural tissues by disturbing the microvascular circulation.
It is also important to consider whether the basal
membrane has been destroyed in the fascicule or not.
After IMIs, intramuscular fibroblast proliferation occurs,
causing fibrosis, and the fibrosis subsequently results in
constriction of the tissues surrounding the peripheral
nerve. By this mechanism, nerve perfusion is decreased
[21,20]. Nerve fibers are directly exposed to neurotoxic
agents when injections are applied to the endoneurial
compartment. On the other hand, extrafascicular injections
do not cause neural damage every time, but injuries may
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occur if the injected agents are highly neurotoxic, such
as penicillin G, diazepam, or chlorpromazine. Our study
and other previous animal experiments have shown that
even saline, which has no neurotoxic effects if injected
into the intrafascicular compartment, may cause edema in
such cases. This causes increased intrafascicular pressure
and ischemia. More neurotoxic agents may cause axonal
destruction and Wallerian degeneration in addition to
edema [7,8,22]. In our study, similar pathological changes
were observed in the subgroups that received penicillin G
and diclofenac sodium.
Neurological examinations and electrophysiological
studies yielded parallel results. The histopathological
changes in the penicillin G subgroups were the most
statistically significant; thus, the neurotoxicity of the
penicillin drug group is very high [3,2,17]. This was
followed by the diclofenac sodium and saline subgroups
in the present study. Intraneural inflammatory cell
infiltration was found to be significant for the penicillin
G and diclofenac sodium groups. Dexamethasone was the
mildest agent of this study in terms of histopathological
changes. This is probably a result of the antiinflammatory
effects of dexamethasone. In contrast, it was interesting
that endoneurial saline infusion caused Wallerian
degeneration in this study. This may have been the result of
increased pressure and ischemia arising from fast injections
performed manually [2,15]. Low-pressure injections may
cause transient changes, but fast high-pressure injections
may cause severe functional and structural changes
[14,17]. Hadzic et al. evaluated neurological results and
changes with increasing pressure in dogs as a result of
intrafascicular injections and demonstrated that high
pressure may cause severe neurological disorders and
fascicular damage [17]. Kokhan et al. conducted a study
with 22 patients and showed that local anesthetic injections
of 1 mL may raise the pressure in the sciatic nerve by 40
mmHg [23]. Therefore, the amount of the drug injected
is also important because pressure increases with that
amount, as does neural damage.
In conclusion, our study has demonstrated that any
IMI applied to the region of the sciatic nerve may cause
histopathological damage depending on the chemical and
neurotoxic properties of the injection. Both permanent
and temporary neurodeficiencies may occur according
to the injection compartment that is used. Furthermore,
the amount, injection speed, and neurotoxicity of
the pharmaceutical agent will also affect the clinical
presentation. According to our study and the relevant
literature, permanent or temporary sciatic nerve injection
injuries may occur if injections are applied to the piriform
fossa with or without use of the endoneurial compartment.
Following appropriate application procedures will protect
the sciatic nerve even in the event of nerve variations.
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